{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T00:36:21Z","timestamp":1769819781045,"version":"3.49.0"},"reference-count":26,"publisher":"Cambridge University Press (CUP)","issue":"5","license":[{"start":{"date-parts":[[2021,7,27]],"date-time":"2021-07-27T00:00:00Z","timestamp":1627344000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CNS Spectr."],"published-print":{"date-parts":[[2022,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec id=\"S1092852921000687_sec1\"><jats:title>Objective<\/jats:title><jats:p>Obsessive\u2013compulsive disorder (OCD) is a severe psychiatric disorder characterized by its heterogeneous nature and by different dimensions of obsessive\u2013compulsive (OC) symptoms. Serotonin reuptake inhibitors (SRIs) are used to treat OCD, but up to 40% to 60% of patients do not show a significant improvement with these medications. In this study, we aimed to test the impact of brain-derived neurotrophic factor (BDNF) Val66Met polymorphism on the efficacy of antidepressants in OCD overall, and in relation to the different OC dimensions.<\/jats:p><\/jats:sec><jats:sec id=\"S1092852921000687_sec2\" sec-type=\"methods\"><jats:title>Methods<\/jats:title><jats:p>In a 6-month prospective treatment study, 69 Caucasian OCD patients were treated with escitalopram for 24\u00a0weeks or with escitalopram for 12\u00a0weeks followed by paroxetine for an additional 12-week period. Patients were genotyped and assessed for treatment response. The main clinical outcomes were improvement of the Yale-Brown Obsessive\u2013Compulsive Scale score and in different OC symptom dimension scores.<\/jats:p><\/jats:sec><jats:sec id=\"S1092852921000687_sec3\" sec-type=\"results\"><jats:title>Results<\/jats:title><jats:p>The Val\/Val group comprised 43 (62%) patients, the Val\/Met and Met\/Met group comprised 26 (38%) patients. Forty-two patients were classified as responders at 12\u00a0weeks and 38 at 24\u00a0weeks; no significant association was found between BDNF Val66Met and SRIs response at 12 and 24\u00a0weeks. In analyses of the different OC symptom dimensions, the Met allele was associated with a slightly reduced score in the aggressive\/checking dimension at 6\u00a0months (<jats:italic>P<\/jats:italic>\u00a0=\u00a0.048).<\/jats:p><\/jats:sec><jats:sec id=\"S1092852921000687_sec4\" sec-type=\"conclusions\"><jats:title>Conclusions<\/jats:title><jats:p>Our findings do not support the usefulness of BDNF Val66Met genotyping to predict overall response to treatment with SRIs in OCD; they did however suggest a better outcome at 6\u00a0months for the aggressive\/checking symptom dimension for patients carrying the Met allele.<\/jats:p><\/jats:sec>","DOI":"10.1017\/s1092852921000687","type":"journal-article","created":{"date-parts":[[2021,7,27]],"date-time":"2021-07-27T09:44:43Z","timestamp":1627379083000},"page":"645-651","source":"Crossref","is-referenced-by-count":1,"title":["Impact of brain-derived neurotrophic factor Val66Met polymorphism and response to escitalopram or paroxetine in obsessive\u2013compulsive disorder"],"prefix":"10.1017","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1953-0509","authenticated-orcid":false,"given":"Ghina","family":"Harika-Germaneau","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas","family":"Langbour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sylvie","family":"Patri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcello","family":"Solinas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Armand","family":"Chatard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno","family":"Millet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farshad","family":"Hashemian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie-Christine","family":"P\u00e9rault-Pochat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nematollah","family":"Jaafari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8970-5514","authenticated-orcid":false,"given":"Claire","family":"Lafay-Chebassier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"56","published-online":{"date-parts":[[2021,7,27]]},"reference":[{"key":"S1092852921000687_r1","doi-asserted-by":"publisher","DOI":"10.1038\/mp.2008.94"},{"key":"S1092852921000687_r13","doi-asserted-by":"publisher","DOI":"10.1016\/0165-0327(90)90081-I"},{"key":"S1092852921000687_r9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajp.2017.10.014"},{"key":"S1092852921000687_r5","doi-asserted-by":"publisher","DOI":"10.1038\/nrn3379"},{"key":"S1092852921000687_r20","doi-asserted-by":"publisher","DOI":"10.1038\/mp.2015.32"},{"key":"S1092852921000687_r2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2009.06.010"},{"key":"S1092852921000687_r22","doi-asserted-by":"publisher","DOI":"10.1037\/a0024159"},{"key":"S1092852921000687_r21","doi-asserted-by":"publisher","DOI":"10.1016\/j.eurpsy.2011.09.005"},{"key":"S1092852921000687_r25","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v68n0512"},{"key":"S1092852921000687_r18","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2008.47"},{"key":"S1092852921000687_r15","doi-asserted-by":"publisher","DOI":"10.1038\/mp.2010.98"},{"key":"S1092852921000687_r4","doi-asserted-by":"publisher","DOI":"10.24869\/psyd.2019.141"},{"key":"S1092852921000687_r7","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.0348-04.2004"},{"key":"S1092852921000687_r24","doi-asserted-by":"publisher","DOI":"10.1111\/appy.12148"},{"key":"S1092852921000687_r11","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2009.05.017"},{"key":"S1092852921000687_r12","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1520-6394(1998)7:1+<11::AID-DA4>3.0.CO;2-I"},{"key":"S1092852921000687_r16","first-page":"22","article-title":"The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10","volume":"59","author":"Sheehan","year":"1998","journal-title":"J Clin Psychiatry."},{"key":"S1092852921000687_r3","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.162.2.228"},{"key":"S1092852921000687_r17","first-page":"8","article-title":"Neuropharmacology of paroxetine","volume":"37","author":"Nemeroff","year":"2003","journal-title":"Psychopharmacol Bull."},{"key":"S1092852921000687_r8","first-page":"611","article-title":"No association between BDNF Val66Met polymorphism and treatment response in obsessive\u2013compulsive disorder in the Japanese population","volume":"12","author":"Umehara","year":"2016","journal-title":"Neuropsychiatr Dis Treat."},{"key":"S1092852921000687_r14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychires.2008.03.014"},{"key":"S1092852921000687_r10","doi-asserted-by":"publisher","DOI":"10.1037\/pha0000297"},{"key":"S1092852921000687_r26","doi-asserted-by":"publisher","DOI":"10.2147\/NDT.S163946"},{"key":"S1092852921000687_r19","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2017.06.037"},{"key":"S1092852921000687_r23","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.b.30930"},{"key":"S1092852921000687_r6","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(03)00035-7"}],"container-title":["CNS Spectrums"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S1092852921000687","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,25]],"date-time":"2022-10-25T10:26:41Z","timestamp":1666693601000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S1092852921000687\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,27]]},"references-count":26,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["S1092852921000687"],"URL":"https:\/\/doi.org\/10.1017\/s1092852921000687","relation":{},"ISSN":["1092-8529","2165-6509"],"issn-type":[{"value":"1092-8529","type":"print"},{"value":"2165-6509","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,27]]}}}